Pharming Group reports financial results for the first nine months of 2020
Pharming Group N.V. presents its (unaudited) financial report for the nine months and third quarter ended 30 September 2020.
Continued solid performance and strong recovery of sales in Q3 2020
Delivered 9.2% increase in revenues, 19.8% increase in operating profit and 6.4% increase in net profit (59% increase on constant currency basis) year-on-year for the first nine months of 2020
Company has initiated the process for a secondary listing in the US on Nasdaq